Kenichi Mori

Also affiliated with Astellas Pharma (Japan)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations”.

Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations

Blood Advances(2020)10.1182/bloodadvances.2019000919

N/A

0DataRank · unranked

78 citations

Jason E. Hill, Leena Rahmat, Alexander E. Perl, Erkut Bahceci, Kenichi Mori +2 more

Effects of dutasteride in a rat model of chemically induced prostatic inflammation—Potential role of estrogen receptor β

The Prostate(2020)10.1002/pros.24071

N/A

0DataRank · unranked

1 citations

Kenichi Mori, Toshitaka Shin, Zhou Wang, Donald Defranco, Naoki Yoshimura +2 more